These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 288486)

  • 1. Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia.
    Stein RS; Flexner JM; Graber SE
    Blood; 1979 Sep; 54(3):636-41. PubMed ID: 288486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of lithium to limit neutropenia significantly during induction therapy of acute myelogenous leukemia. A Southeastern Cancer Study Group study.
    Stein RS; Vogler WR; Lefante J
    Am J Clin Oncol; 1984 Aug; 7(4):365-9. PubMed ID: 6430063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
    Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
    Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial.
    Stein RS; Flexner JH; Graber SE
    Adv Exp Med Biol; 1980; 127():187-97. PubMed ID: 6931477
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of lithium to reduce period of neutropenia during induction therapy of acute myeloid leukemia.
    Scarffe JH; Chang J
    Hematol Oncol; 1989; 7(1):69-75. PubMed ID: 2491829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium and granulocytopenia during induction treatment of adult acute lymphoblastic leukemia.
    Bandini G; Ricci P; Ruggero D; Cantore M; Visani G; Tura S
    Tumori; 1982 Oct; 68(5):427-30. PubMed ID: 6960590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
    Masaoka T; Ogawa M; Yamada K; Kimura K; Ohashi Y
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
    Kurrle E; Hoelzer D; Heimpel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
    Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
    Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lithium and acute myeloid leukemia].
    Witz F; Rigon JL; Lederlin P; Aymard JP; Rumilly F; Eisenmann JC; Herbeuval R
    Sem Hop; 1983 Feb; 59(8):559-60. PubMed ID: 6302903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
    Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
    Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of lithium carbonate in neutropenia induced by antiblastic agents and evaluation of its long-term efficacy].
    Spina MP; Ventura M; Lavecchia G; Bombara R; Giraldi B; Mensi F; Massari A; Rossi F; Santi G; Visca U
    Minerva Med; 1981 Dec; 72(49):3323-8. PubMed ID: 6796912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occurrence of infectious complications during therapy for acute leukemia].
    Lukásová M; Sedlácková M; Libánský J
    Vnitr Lek; 1979 Jun; 25(6):542-9. PubMed ID: 288237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.